We studied the effect on protein degradation of agents that alter intracellular adenosine 3',5'-monophophate (cyclic AMP) in isolated rat right atria. Protein degradation rate was determined by measurement of the rate of release of L-tyroslne from atria cultured in the presence of cycloheximide. Stimulation of adenylate cyclase activity by either L-isoproterenol, glucagon, prostaglandin Ei, prostaglandin E2 or cholera toxin produced a 23-43% decrease in tyrosine release rate. L-Isoproterenol (1 fiM) lowered the protein degradation rate both in the presence (27 ± 3%) or absence (25 ± 2%) of insulin. In constrast, the a-adrenergic agonist methoxamine (10 JIM) increased the rate of tyrosine efflux. The phosphodiesterase inhibitors papaverine (0.1 mM) and theophylline (1 mM) reduced tyrosine release rate by 62 ± 2% and 25 ± 2%, respectively. The cyclic nucleotide analog dibutyryl cyclic AMP produced a 23 ± 4% reduction in tyrosine efflux rate, an effect that may be in part due to butyrate released by hydrolysis. Both carbamylcholine and nitroprusside, agents which activate guanylate cyclase, had no apparent effect on the rate of overall protein degradation. In experiments with atria labeled in vitro with radioactive tyrosine, the degradation rate of soluble cell proteins fractionated by gel filtration was uniformly decreased by L-isoproterenol over a wide molecular weight range. Comparison of degradation rate to protein kinase activation, high energy phosphate levels and beating rate show that suppression of degradation is more closely correlated with mechanical activity or energy depletion than with cyclic AMP content. Therefore, these data do not establish whether cyclic AMP modifies protein degradation directly, or by effects secondary to increased contractile activity. Ore Res 49: 80S-617, 1981 et al., 1978), we have examined the effect on cardiac protein degradation of agents that alter intracellular cyclic AMP. These investigations were carried out on spontaneously beating isolated rat right atria by measuring tryosine release in the presence of cycloheximide.
CARDIAC hypertrophy is an important adaptive response to a variety of physiological and pathological stimuli. Even though this adaptive process is of considerable clinical and fundamental significance, the biochemical mechanisms controlling the balance between protein synthesis and degradation are poorly understood. The administration of catecholamines in vivo has been used widely as a model for the experimental induction of cardiac hypertrophy and is associated with increased rates of protein synthesis in adult and neonatal hearts (Mallov, 1973; Claycomb, 1976) . Recently, it has been found that this enhancement of protein synthesis can be produced in vitro (Kaellfelt et al., 1976; Chua et al., 1978) using the isolated perfused heart and therefore may be due in part to a direct effect on the myocardium. In view of the pronounced stimulation of cardiac adenylate cyclase by /?-adrenergic agonists and the known modulation of protein turnover associated with adenosine 3',5'-monophosphate (cyclic AMP) in several systems (Woodside et al., 1974; Garber et al., 1976; Dazord et al., 1977; Chua VOL. 49, No. 3, SEPTEMBER 1981 isoproterenol was added contained 1 mM ascorbic acid to retard catechol oxidation. Before use, each buffer was equilibrated for 30 minutes with 95% O2: 5% CO2 at 37°, adjusted to pH 7.40 and filtered through 0.45-/xm cellulose acetate filters (Millipore Corp) . Experimental agents were added immediately before use.
Preparation of Atria
Male Sprague-Dawley rats (150-200 g) were maintained with free access to laboratory chow and water. One hour prior to use, each animal was injected intraperitoneally with heparin (1.5 U/g) in 0.5 ml water. The rats were killed by a blow to the cervical spine, and the heart was removed and placed in warm KRB within 20 seconds. When the chambers had pumped free of blood, the heart was transferred to fresh KRB, and the right atrium was removed. Only atria that continued to contract rhythmically were used.
Measurement of TyrosLne Release
Excised atria were incubated for 30 minutes in 3 ml of oxygenated KRB at 37° and then transferred to 1.0 ml KRB containing 0.5 mM cycloheximide which was continuously oxygenated in a shaking water bath. At 10-minute intervals, the incubation medium was removed and replaced with fresh medium. The medium removed was added to 0.25 ml 50% trichloroacetic acid (TCA), and the supernatant of a 20-minute centrifugation at 2500 g was assayed for tyrosine fluorometrically (Waalkes and Udenfriend, 1957) . Control tyrosine release rates were determined by linear regression analysis of the total tyrosine released into the medium between 10 and 40 minutes in the presence of cycloheximide. From 40 to 80 minutes, the added media contained the various experimental agents indicated, in addition to cycloheximide. The release rate for these interventions was determined by linear regression between 50 and 80 minutes. The correlation coefficients for the least-squares lines were greater than 0.98 in all cases. At 80 minutes, each tissue was homogenized in 1.5 ml 10% TCA for determination of tyrosine content and total protein (Lowry et al., 1951) .
Measurement of Cyclic AMP
Excised atria that had been incubated for 30 minutes in KRB were transferred to 2.0 ml KRB containing isoproterenol. After 2 minutes, the atria were clamped in metal tongs maintained at the temperature of liquid nitrogen. The frozen atria were stored at -70 c C overnight before they were analyzed for cyclic AMP by the procedure of Harper and Brooker (1975) .
Statistical Methods
For multiple comparisons with a single control, the criterion of Bonferroni was used to restrict the probability of a falsely significant result (Miller, 1967) . By this test, the family error rate for n comparisons will be less than 0.05 if the null hypothesis for each individual comparison is evaluated by a two-tailed t-test at a significance level of 0.05/ n. This procedure has the advantages of not requiring equality of variances or equal group sizes. Student's ^-values were determined as described by Dixon and Massey (1957) , and the associated probability values were calculated by series expansion (Abramowitz and Stegun, 1965) . The value used for the degrees of freedom was N-k, where N was the total number of measurements in all groups and k was the number of groups (Wallenstein et al., 1980) . All measures of variability listed in "Results" are standard errors of the mean.
Double-Label Experiments
Twelve right atria were incubated at 37°C in oxygenated KRB supplemented with 0.1 U/ml insulin and rat plasma levels of all amino acids (Morgan et al., 1971) . Medium for eight of the atria contained 1 juCi/ml [ 14 C( £/)]L-tyrosine. The remaining four atria were incubated in the presence of 1 jaCi/ml [ 3 H(G)]L-tyrosine. After 4 hours, incorporation of labeled tyrosine was terminated by incubating the atria two times for 30 minutes in radioisotope-free medium containing 2 mM-L-tyrosine. At the end of the second chase period, the 3 Hlabeled atria were frozen in liquid nitrogen and stored at -70°C. The u C-labeled tissues were transferred to fresh medium containing 2 mM L-tyrosine. Incubation medium for four of these atria contained 1 fiM L-isoproterenol. After an additional 20 hours incubation, all atria were frozen. The tissue from each of the three groups was then homogenized in 5 ml 0.1 M NaCl-0.05 M sodium borate, pH 9.0, and centrifuged 15 minutes at 20,000 g. The supernatants were precipitated by addition of TCA to a concentration of 10%, and the pellets formed by centrifugation for 15 minutes at 2000 g were solubilized in 3 ml of 1% sodium dodecyl sulfate (SDS)-0.01 M sodium borate, pH 9.0, and dialyzed against the same buffer for 16 hours. Two final samples were then made from these three extracts. The control sample consisted of 3 H-labeled protein and an equal quantity of l4 C-labeled protein from those atria incubated without isoproterenol. The experimental sample was similar except that the u C-labeled protein was from atria exposed to isoproterenol. Each sample was chromatographed by gel filtration on a 1.2 X 60 cm column of Sepharose 6B (Pharmacia) eluted with borate-SDS buffer. Aliquots of the eluted fractions were counted simultaneously for 3 H and M C in a liquid scintillation spectrometer, and the results were expressed as the ratio of 3 H dpm to M C dpm.
ATP and Creatine Phosphate Measurements
Atria used for measurement of ATP and creatine phosphate were incubated using the same protocol as for tyrosine release determinations. Eight min-utes after addition of isoproterenol or prostaglandin Ei at the indicated concentrations, the beating rates were counted, and at 10 minutes the atria were frozen rapidly by clamping in metal tongs maintained at liquid nitrogen temperatures and stored at -70°C. The tissues were homogenized at -5°C in 3 M HC1O 4 which was then diluted to 0.7 M and immediately neutralized by addition of 0.25 volumes of 0.5 M KC1, 2.1 M KOH, 0.25 M Tris-OH. Precipitated KCIO4 was removed by centrifugation for 10 minutes at 2500 g, and the supernatant was analyzed for ATP and creatine phosphate by a fluorometric assay described by Lowry and Passonneau (1972) . To inhibit residual adenylate kinase activity all reaction mixtures contained 10 fig/ml P ! ,P 5di(adenosine-5')-pentaphosphate (Lienhard and Secemski, 1973) .
Protein Kinase Assay
Atria used for determining the degree of protein kinase activation were incubated by the same procedure described above for ATP measurements. Protein kinase was extracted by minor modifications of the method of Hayes et al. (1979) . Phosphorylation of histone was measured by a phosphocellulose paper assay (Witt and Roskoski, 1975) . Kinase activity is expressed as the ratio of phosphorylating activity in the absence of added cyclic AMP to that in the presence of 10 ^IM cyclic AMP.
Results
In a previous report (Curfman et al., 1980) , we showed that measurement of the release of L-tyrosine from rat isolated left atria incubated in KRB medium containing 0.5 mM cycloheximide to inhibit protein synthesis is a valid technique for determining the rate of protein degradation. When amino acid re incorporation is blocked by addition of cycloheximide to an atrial preparation, there is an immediate increase in the release into the medium of L-tyrosine, an amino acid which is neither synthesized nor degraded by rat myocardium. During the interval for which tyrosine efflux remains constant, the rate of tyrosine release is a direct measure of the rate of protein degradation. In the present study, this procedure was applied to spontaneously beating rat right atria to determine the effect on protein degradation of agents that alter intracellular cyclic AMP concentration. Figure 1 illustrates the accumulated release of L-tyrosine from a group of eight beating right atria incubated at 37°C in oxygenated KRB containing 0.5 mM cycloheximide. At 32 minutes, 1.0 /IM Lisoproterenol was added to the medium of four of the atria. Within 8 minutes after addition of isoproterenol, tyrosine efflux fell by 30% and then remained constant at this lower value. Similar experiments showed that the accumulation of tyrosine in medium containing cycloheximide is linear for at least 90 minutes, both in the presence and absence of isoproterenol. In Table 1 , the rates of tyrosine release are listed for a series of experiments in which each atrium was incubated for 40 minutes in KRB to determine control rate and then transferred for an additional 40 minutes to medium containing the indicated experimental agents. Control incubations containing only KRB plus cycloheximide showed no significant change in the rate of tyrosine release measured from 10 to 40 minutes (2.79 ± 0.03, n -384) and from 50 to 80 minutes (2.69 ± 0.10 nmol/mg protein per hr, n = 61). However, addition of isoproterenol at 40 minutes caused the rate of tyrosine efflux to decrease significantly to 1.88 ± 0.08 nmol/mg protein per hr. At the end of the exposure to isoproterenol, there was no significant difference (0.15 ± 0.09 nmol/mg protein) in the total tissue tyrosine content of control and isoproterenol-exposed atria. Since the decreased accumulation in the medium was not compensated by a corresponding increase in intracellular tyrosine, the diminished rate of tyrosine release indicates a true suppression of protein degradation attributable to isoproterenol.
To interpret the statistical significance of data presented in Table 1 , we have used the Bonferroni criterion described in Methods. With the exception of papaverine, no significant differences in the val- Individual atna were incubated for 80 minutes in KRR buffer containing 0 5 ITLM cycloheximide. For each atrium, the rate of tyrosine releaae into the medium was determined during an initial 40-minute control incubation and during a subsequent 40-minute incubation in the presence of the individual eipenmental agents. Tissue tyrosine content was measured at the end of the second period. Tne percentage change* in tyroeine release rates were calculated using each atrium HS its own control. P designates the probability of no true difference between the control and experimental percentage change. To maintain the family error rate at 0.05 or lesa, individual comparisons were not considered significantly different unless P was leas than 0.003 for 320 degrees of freedom. Numbers of individual atria studied under each set of conditions are shown in parentheses ues for tissue free tyrosine content were found between any of the experimental conditions and the controls. Therefore, we have based statistical decisions about the effectiveness of the various compounds on the percentage change in the rate of tyrosine release into the medium, using each atrium as its own control. This procedure has the advantage of taking into account the observed variability in the rate of tyrosine efflux among individual atria.
When 10 IMM D,L-propranolol was added simultaneously with 1 HM isoproterenol, the effect of isoproterenol was substantially reduced, and the residual suppression of degradation rate was not statistically significant (Table 1) . However, when the atria were first incubated for 40 minutes in 1 /IM isoproterenol before the addition of propranolol, there was no increase in the rate of tyrosine release in the next 40-minute period (0.9 ± 3%, n = 4), despite the presence of propranolol. Therefore, although propranolol blocked the suppression of degradation due to isoproterenol, it did not readily reverse the effect once established.
To determine the sensitivity of protein degradation to isoproterenol, atria were exposed to concentrations from 2.5 X 1O" 10 to 10" 6 M. The data in Figure 2 show the response of the rate of tyrosine release expressed as percent of the control rate for
FIGURE 2 Concentration-effect relationship for isoproterenol-induced suppression of atrial protein degradation. Each point is the average rate of tyrofiine release for five atria incubated in isoproterenol from 40 to 80 minutes, expressed as percent of the release rate for the same atria in the absence of isoproterenol from 0 to 40 minutes. The solid line represents the response expected for a Kr> of 5.4 nM and a maximal suppression of 30%. the same atria. Maximal suppression occurs at 10 ' M and higher. The solid line drawn through the data points represents the response expected for a simple bimolecular hormone-receptor reaction for which the dissociation equilibrium constant is 5.4 nM and 30% reduction in degradation rate corresponds to complete receptor occupancy. Over a similar concentration range, beating rates increased from a control value of 194 ± 4 to a maximum of approximately 289 beats/min ( Table 2 ). The chronotropic effect had a half-maximal response at approximately the same isoproterenol concentration as suppression of degradation. In contrast, the threshold for detecting an increase in either cyclic AMP (Fig. 3) or protein kinase activation (Table 2 ) is significantly higher than that shown for degradation.
Having documented reduced protein degradation rates in the presence of the /3-adrenergic agonist isoproterenol, we determined the effects of other agents known to elevate cyclic AMP levels by stimulating adenylate cyclase activity. Table 1 shows that 1 JUM glucagon, 1 ^M prostaglandin E 2 , and 30 liM prostaglandin Ei each significantly reduced the rate of tyrosine release without appreciably changing tissue tyrosine content. Since these agents stimulate cardiac adenylate cyclase through mechanisms distinct from the /3-adrenergic receptor, the suppression of protein degradation does not appear to be restricted to a specific receptor type. This conclusion is supported by the observation (Table  3 ) that incubation of atria in the presence of 0.5 /XM cholera toxin reduces the rate of tyrosine release by 43% without significantly altering intracellular tyrosine concentration. The mechanism by which cholera toxin stimulates adenylate cyclase is thought to involve direct modification of the cyclase regulatory subunit (Moss and Vaughan, 1979) and to be independent of hormone binding.
It has been reported that a-adrenergic effectors decrease cyclic AMP in isolated rat hearts and rat cardiac myocytes (Watanabe et al., 1977) . This is consistent with our finding (Table 1) that 10 fiM methoxamine, an a-adrenergic agonist, enhances protein degradation as indicated by a significant increase in tyrosine efflux. The effect of methoxamine was blocked by the a-adrenergic-specific antagonist, phentolamine. When atria were incubated in 0.25 mM dibutyryl cyclic AMP to increase the intracellular concentration of this cyclic AMP analog without activation of adenylate cyclase, the rate of tyrosine production decreased by 23%. To test the possibility that this effect was caused by breakdown products, tyrosine release was also measured in the presence of 0.25 mM 5'-AMP and 0.5 mM sodium butyrate (Table 1) . Neither agent produced an effect significantly different from the control. However, the difference in the suppression of tyrosine release between dibutyryl cyclic AMP and butyrate did not quite achieve 1.6* 1.9* 2.0* 0.9* Measurements were made on atria incubaied 40 minutes in KRB-cycloheiimide medium and then transferred to medium containing the indicated agenu? Beating rate was measured between 8 and 10 minute*. All oLher parameters were determined using atna freeze-clamped at 10 minutes. The tabulated values are the average ± 3E. Eight replicates were used for prostaglandin; and six, for each other condition.
" Indicate* that a measurement is significantly different from IU control at the 0 01 level and that the error rate for all five comparisons is less than 0. OV5. 1.08 ± 0.08 1.03 ± 0.06
Two groups of six atria each were incubated 2 hours at 37°C in KRB in the presence (toiin-lreated) or absence (control) of 0 5fiM cholera toxin and then transferred to Rimilar media containing 0 5 mM cycloheximide for measurement of tyroaine efflux during the next 40 minutes The P value for the difference in release rates is 0.002 statistical significance (P = 0.024). 8-Br cyclic AMP did not change degradation significantly.
Three classes of phosphodiesterase inhibitors were investigated for their influence on atrial protein degradation (Table 1) . Both theophylline (1 mM) and papaverine (0.1 miw) effectively decreased the rate of tyrosine release. Although papaverine increased the intracellular free tyrosine concentration, there still was a net decrease in tyrosine production by atria exposed to this agent. Ro 7-2956, an inhibitor reported to simulate the mechanical response to /9-adrenergic agonists (Tsien, 1977) , had no significant effect at a concentration of 0.1 mM.
To determine whether cyclic GMP also alters protein turnover, atria were incubated in the presence of the guanylate cyclase activating agents carbamyl choline and sodium nitroprusside. No significant change in tyrosine release was detected in either case (Table 1) .
We have shown previously that insulin exerts a marked effect on the protein degradation rate in isolated rat left atria, decreasing the rate of tyrosine release in the presence of cycloheximide by 38% (Curfman et al., 1980) . In view of the known influence of insulin on protein degradation rates in a number of tissues (Goldberg and St. John, 1976) , further studies of the interaction between insulin and isoproterenol in the modulation of myocardial protein degradation were of interest. In Table 4 are summarized values for the decrease in tyrosine loss into the medium and accumulation in the tissue when insulin (0.1 U/ml) was present throughout the incubation. The percent decrease in the rate of tyrosine release on addition of isoproterenol is comparable to that observed in the absence of insulin (Table 1 ). Since the effects of these two agents appear to be additive, it seems likely that they suppress protein degradation by different mechanisms.
To determine whether isoproterenol suppresses protein degradation uniformly or is selective for specific proteins, we examined the relative degradation rates of atrial proteins fractionated by gel chromatography in the presence of SDS. In this experiment, which is a modification of the double isotope procedure devised by Arias et al. (1969) , atria were incubated for 4 hours in an enriched medium containing either 3 H-or M C-labeled tyrosine. After a brief chase to remove unincorporated radioisotope, the 3 H-labeled atria were frozen and the H C-labeled atria were incubated for an additional 20 hours either in the presence or absence of 1 ^IM L-isoproterenol. During this period, the proteins in each group of H C-labeled atria turn over at their own characteristic rates. When equal masses of proteins labeled with the two isotopes are then combined, those proteins that were more rapidly degraded and have a lower U C specific activity will exhibit greater 3 H/ 14 C ratios. Figure 4 illustrates the results obtained for atrial proteins extracted with 0.1 M NaCl. In agreement with the results presented above, proteins from atria incubated in the absence of isoproterenol had higher ' 1 H/ U C ratios and, hence, were degraded at a greater rate than those incubated in its presence. There is no apparent selectivity in the effect over the range of molecular weights shown. It should be emphasized, however, that the relatively brief labeling period employed favors isotope incorporation into proteins which turn over more rapidly. As a consequence, these results do not neceassarily indicate the effect of isoproterenol on the myofibrillar proteins, which turn over more slowly.
Since many of the agents examined in this report produce increased contractile activity in the heart, it was important to determine how the rate of atrial beating related to intracellular high-energy phosphate reserves. The data in Table 2 illustrate that ATP and creatine phosphate levels measured after 10 minutes of incubation decrease with increasing isoproterenol concentration in a fashion closely correlated to the degradative and chronotropic responses. In addition, 30 fiM prostaglandin Ei reduced protein degradation rate (Table 1) and highenergy phosphate stores without a measurable change in the activation ratio of protein kinase (Table 2 ). These observations suggest that energy The experiments summarized here are similar to those described in Table I except thai insulin (0.1 U/ml) was present throughout the 80-minute incubation with cycloheximide The P value for the difference in percent rale change between control and isoproterenol-treated atria is 0 006, n \alues are shown in parentheses FIGURE 4 Double-label experiment demonstrating isoproterenol-induced suppression of myocardial protein degradation. Circles represent the 3 H/ U C dpm ratio for protein from atria incubated under control conditions as described in Methods. Triangles correspond to the values for isoproterenol-exposed atria. Only fractions with counting rates of 200 dpm or greater for each isotope are shown. The fractions shown span a molecular weight range of 95,000 to 5,000 daltons. FRACTION depletion may in part be responsible for the suppression of degradation resulting from agents that increase cellular cyclic AMP.
Discussion
A regulatory role of cyclic AMP on protein degradation has been suggested for several organ systems. One of the earliest reports showed that glucagon and epinephrine cause a net loss of protein from liver both by inhibiting protein synthesis and enhancing degradation (Woodside et al., 1974) . In contrast to the liver, in which proteolysis is increased, cyclic AMP has been observed to have an anabolic effect in other systems. Daily isoproterenol injections increased the mean half-life of radiolabeled mouse parotid gland protein by 84% (Hill and Malamud, 1974) . A similar response was observed for the turnover of protein from adrenal glands of rats given ACTH (Canick and Villee, 1974) and from a mouse adrenal cell line exposed to either ACTH or dibutyryl cyclic AMP (Dazord et al., 1977) . Garber et al. (1976) found that either epinephrine or isoproterenol reduced the release of both alanine and glutamine from isolated rat epitrochlaris and that this effect could be blocked by the /?-adrenergic antagonist propranolol. Because glucagon, PGE 2 , and the a-agonist phenylephrine did not modify amino acid release, they concluded that the suppression of protein degradation in skeletal muscle is mediated by /?-adrenergic receptors. In a subsequent study, this conclusion was extended to D-class serotonin receptors when it was observed that 5hydroxytryptamine also increased cyclic AMP and reduced the rate of alanine and glutamine release (Garber, 1977) .
In agreement with our own results, Chua et al. (1978) , in a preliminary report, observed that, in the rat heart Langendorff preparation, either epinephrine (10 fiM), glucagon (1 /*M), or insulin (25 mU/ml) reduced protein degradation by 30-40%. However, when insulin-treated hearts were exposed to glucagon or epinephrine, there was no additional suppression of proteolysis. The reasons for this discrepancy between their findings and our observation that the effects of insulin and isoproterenol on protein degradation are additive are uncertain, but may be related to differences in the experimental preparation.
The results of the studies reported here indicate that suppression of protein degradation in isolated rat atria is associated with agents which increase levels of cyclic AMP by three means: activation of adenylate cyclase, phosphodiesterase inhibition, and action as cyclic AMP analogs. The most consistent results were obtained by adenylate cyclase activation. Isoproterenol, glucagon, prostaglandin E2Q, and cholera toxin, each of which activates adenylate cyclase in a different way, all cause a sustained decrease in the release of tyrosine derived from proteolysis.
Both papaverine and theophylline mimicked the effect of adenylate cyclase activation in reducing protein degradation. However, results obtained with phosphodieterase inhibitors must be interpreted cautiously. Methylxanthine derivatives can cause the release of endogenous catecholamines and alter intracellular calcium availability (Stull and Mayer, 1979) . Moreover, papaverine in some systems inhibits the slow inward calcium current (Schneider et al., 1975) and reduces ATP production in mitochondria (Browning et al., 1974) . Since both ATP (Chua et al., 1979) and calcium (Kameyama and Etlinger, 1979) have been implicated in the regulation of muscle protein turnover, it is at present not certain that the suppression of degradation by these phosphodiesterase inhbitors can be attributed entirely to increased intracellular cyclic AMP levels.
Addition of dibutyryl cyclic AMP to atrial cul- VOL. 49, No. 3, SEPTEMBER 1981 tures resulted in a 23% decrease in tyrosine release rate. Since it is known that, in bicarbonate buffers, this derivative undergoes hydrolysis with release of butyrate (Swislocki, 1970) , it is possible that part of the effect measured with the cyclic nucleotide derivative is not related to its action in increasing intracellular cyclic AMP. The evidence discussed to this point is suggestive that cyclic AMP elevation in isolated beating atria leads to reduced protein degradation. However, when the decrease in protein degradation (Fig. 2) is compared to the increase in cyclic AMP levels (Fig.  3) or cyclic-AMP-dependent protein kinase activity (Table 2) , it is evident that suppression of degradation occurs over a range of isoproterenol concentrations in which there is minimal change in either of these parameters. This apparent dissociation of proteolysis from cyclic AMP does not necessarily mean that cyclic AMP is not involved in the regulation of degradation. Analogous findings in other systems indicate that activation of phosphorylase in rabbit skeletal muscle occurs at concentrations of isoproterenol that did not measurably elevate cyclic AMP (Stull and Mayer, 1971) , and steroidogenesis has been observed in response to ACTH in adrenal cells and gonadotropin in Leydig cells without detectable change in free cyclic AMP (Beall and Sayers, 1972; Dufau et al., 1973) . Moreover, testosterone production by the Leydig cells has been observed with little or no accompanying change in protein kinase activity (Cooke et al., 1976; Podesta et al., 1976) . Nevertheless, the intermediary role of cyclic AMP in steroid synthesis has been confirmed for both adrenal and testicular cells by demonstration that cyclic nucleotide binding to the regulatory subunit of protein kinase parallels steroidogenesis (Dufau et al., 1977; Sala et al., 1979) . These observations raise the possibility that the physiological response could be prompted by a cyclic AMP increase in a restricted cellular compartment or by an elevated rate of nucleotide turnover without significant changes in its steady state concentration. Since it has been reported that prostaglandin Ei activates a different pool of protein kinase than isoproterenol in the perfused rat heart (Hayes et al., 1979) , the effect of prostaglanding Ej was measured in isolated atria. As with isoproterenol, it was found that a concentration of prostaglandin Ei which suppresses degradation (Table 1) produced no measurable change in protein kinase activity (Table 2) . To resolve this question on the connection between cyclic AMP and cardiac protein degradation, it may be necessary to compare tyrosine release from isolated atria with binding of cyclic AMP to the kinase regulatory subunit.
A more serious concern about the causal link between cyclic AMP and protein degradation is raised by the correlation between ATP depletion and the chronotropic response of atria to isoproterenol. The data in Table 2 show that the reduction of high-energy phosphates and the increase in beating rate both occur over the same range of isoproterenol concentrations in which protein degradation is suppressed. Moreover, prostaglandin Ei at a concentration which reduces protein degradation also lowers high-energy phosphate reserves and increases the rate of contraction. It is clear from this behavior that the energy demands of increased mechanical activity must be taken into account in explaining the inhibition of proteolysis.
In summary, the experiments reported here show that exposure of isolated beating atria to agents that increase cellular cyclic AMP sets into effect a train of events that leads to a suppression of protein degradation. However, because of the observations discussed, we cannot say with certainty that reduced proteolysis is the direct consequence of the regulation of proteolytic enzymes by cyclic AMPmediated phosphorylation. Secondary effects of the increased contractile activity, such as a lowered energy charge or altered ion fluxes, may also be significant. The relative influence of these factors deserves further investigation.
